Targeted DNA/RNA Sequencing Market Analysis By Technology (NGS, Exome Sequencing Seq., Enrichment Seq., Amplicon Seq., Sanger Seq.), By Workflow, By Application, By Type, By End-use, And Segment Forecasts, 2014 - 2025
The global targeted DNA/RNA sequencing market is expected to reach USD 15.9 billion by 2025, according to a new report by Grand View Research, Inc.
Targeted Sequencing has emerged as a key technology in life science research by enabling examination of specific region of interest while keeping the seq. cost as well as complexity of data under manageable limits.
This approach enhances sequencing depth by allowing evaluation of specific coding regions within genes or specific genes, which are known to harbor mutations for disease pathogenesis. Several research projects have employed this technology to avoid wastage of information and extra cost and study only relevant genes. Number of such projects continue to grow, consequently driving the market.
Innovations to address the pitfalls of targeted enrichment method are anticipated to enhance the usage rate of this technology throughout the forecast period. Moreover, with decrease in seq-cost and improvement in informatics, targeted methods have become more accessible for use in clinical settings than ever.
Further key findings from the report suggest: • Next-Generation Sequencing (NGS) technology captured a major share in 2016 • Rapid advancements in NGS and its ancillary protocols can be attributed to the growth of this segment • Out of all the NGS-based targeted methods, exome-seq held the largest share • This can be attributed to the fact that though it accounts for less than 2% of the genome, it contains 85% of the known disease-relevant variants • Entire targeted approach is broken down into presequencing, sequence determination, and data analysis • Being the most crucial step, sequencing accounted for the largest share • This space has revolutionized various applications of life sciences, including human biomedical research, plant & animal sciences, drug discovery, and others • Out of all, human biomedical research is estimated to be the largest application of this space due its high usage in studying disease pathogenesis • The market is bifurcated into DNA-seq and RNA-seq, based on the sample type • DNA-sequencing has been estimated to generate the higher revenue over its counterpart segment. This can be attributed to the presence of wide range of products and kits for DNA-seq • As per end use, academic research is estimated to be the largest segment owing to the increase in seq-based projects at universities and other academic centers • North America held the largest share owing to the presence of effective regulations pertaining to approval of genetic tests and bioinformatics tools • Moreover, the U.S. is observed to have highest number of installed sequencers, which in turn, has contributed to the large share of North America regional market • Asia Pacific is expected to emerge as the fastest growing regional market • Rise in genome-based projects coupled with constant GDP growth in Asian countries is expected to drive the Asia Pacific market • Illumina, Inc.; F. Hoffmann-La Roche Ltd; QIAGEN, Thermo Fisher Scientific, Inc.; and Oxford Nanopore Technologies are some of the major companies operating in this space
Our reports have been used by over 10K customers, including:
This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a "borderless world", cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2,000 cities in over 200 countries....
178 pages •
By Global Industry Analysts
• Apr 2021
- Global RNA Analysis/Transcriptomics Market to Reach $8.7 Billion by 2027
- Amid the COVID-19 crisis, the global market for RNA Analysis/Transcriptomics estimated at US$3.7 Billion in the year 2020, is projected to reach a revised size of US$8.7 Billion by 2027, growing at a CAGR of 13.1% over the analysis...
Global Single-Cell Multi-Omics Market to Reach $3,188.9 Million by 2025 Market Report Coverage - Single-Cell Multi-Omics Market Segmentation • Product Type – Consumables, Instruments, and Software • Sample Type – Human Samples, Animal Samples, and Microbial Samples • Omics Type –...
The global spatial genomics and transcriptomics market is projected to reach USD 404 million by 2025 from USD 178 million in 2020, at a CAGR of 17.8% during the forecast period. Market growth is largely driven by the increasing adoption of spatial genomics and transcriptomics analysis among small companies and startups, expanding applications...
Transcriptomics Technologies Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Transcriptomics Technologies market including the COVID-19 pandemic...
Spatial Genomics & Transcriptomics Market Analysis Report By Technology (FISH, In Situ Sequencing), By Product, By End Use (Translational Research, Diagnostics), And Segment Forecasts, 2019 - 2025
The global spatial genomics & transcriptomics market size is expected to reach USD 262.7 million by 2025., exhibiting...
Transcriptomics Technologies Market Size, Outlook and Growth Opportunities, 2019- 2025 Global Transcriptomics Technologies: By Technology (Microarray, PCR, Gene regulation technologies and Next generation sequencing), By Application (Clinical diagnostics, Drug discovery and research, Bioinformatics and Comparative transcriptomics),...
129 pages •
By Transparency Market Research
• Jul 2016
This report on the global sample preparation market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a robust combination of primary and secondary research. Primary...
Genomics Proteomics And Enabling Technology
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.